- Conditions
- Hypogonadism, Primary Hypogonadism, Secondary Hypogonadism
- Interventions
- Testosterone Undecanoate 750 mg, Testosterone Undecanoate 1000 mg
- Drug
- Lead sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Industry
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 531 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2009
- U.S. locations
- 1
- States / cities
- Lexington, Massachusetts
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1537–1560
of 1,690
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Colorectal Screening
- Interventions
- Colonoscopy and Questionnaire
- Procedure
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Other
- Eligibility
- 50 Years and older
- Enrollment
- 611 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2009
- U.S. locations
- 2
- States / cities
- New York, New York
- Conditions
- Healthy
- Interventions
- wheat bran extract, control wheat bran extract
- Other
- Lead sponsor
- Kellogg Company
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 65 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2009
- U.S. locations
- 1
- States / cities
- Glen Ellyn, Illinois
- Conditions
- Infertility, Male, Gene Abnormality, Sterility, Male
- Interventions
- Stem cell, Genetic Screening, Genetic Reprogramming, Cell Maturation
- Genetic
- Lead sponsor
- CellARTs Inc.
- Industry
- Eligibility
- 18 Years to 60 Years · Male only
- Enrollment
- 100 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2024 – 2027
- U.S. locations
- 1
- States / cities
- San Francisco, California
- Conditions
- Prostate Cancer, Osteoporosis, Hypogonadism
- Interventions
- alendronate
- Drug
- Lead sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- NIH
- Eligibility
- 50 Years to 85 Years · Male only
- Enrollment
- 112 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2002 – 2005
- U.S. locations
- 1
- States / cities
- Pittsburgh, Pennsylvania
- Conditions
- Arterial Stiffness, Blood Pressure, Dysbiosis, Inflammation, Permeability; Increased
- Interventions
- Freeze-dried grape powder, Placebo powder
- Dietary Supplement · Other
- Lead sponsor
- University of California, Davis
- Other
- Eligibility
- 45 Years to 70 Years
- Enrollment
- 40 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025 – 2027
- U.S. locations
- 1
- States / cities
- Davis, California
- Conditions
- HIV, Patient Compliance
- Interventions
- Positive Choices, Personalized Cognitive Counseling
- Behavioral
- Lead sponsor
- Columbia University
- Other
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 202 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2021
- U.S. locations
- 4
- States / cities
- New Haven, Connecticut • New York, New York
- Conditions
- Spinal Cord Injury, Neurogenic Bladder (NB), Neurogenic Lower Urinary Tract Dysfunction, Multiple Sclerosis, Spina Bifida, Urinary Tract Infection(UTI)
- Interventions
- Gentamicin, Lactobacillus Rhamnosus GG
- Drug
- Lead sponsor
- Medstar Health Research Institute
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 48 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2027
- U.S. locations
- 2
- States / cities
- Washington D.C., District of Columbia • Pittsburgh, Pennsylvania
- Conditions
- Neuroendocrine Tumors
- Interventions
- Capecitabine, Temozolomide
- Drug
- Lead sponsor
- Columbia University
- Other
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 41 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2014
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Prostate Cancer (Adenocarcinoma)
- Interventions
- adaptive stereotactic body radiation therapy (SBRT) with a SIB
- Radiation
- Lead sponsor
- Fox Chase Cancer Center
- Other
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 80 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2033
- U.S. locations
- 1
- States / cities
- Philadelphia, Pennsylvania
- Conditions
- Azoospermia, Nonobstructive, Infertility, Male
- Interventions
- Ultrasound-guided rete testis flushing and aspiration
- Procedure
- Lead sponsor
- University of Pittsburgh
- Other
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2027
- U.S. locations
- 1
- States / cities
- Pittsburgh, Pennsylvania
- Conditions
- Spasticity
- Interventions
- Tizanidine, Placebo, Moxifloxacin
- Drug
- Lead sponsor
- Acorda Therapeutics
- Industry
- Eligibility
- 18 Years to 45 Years
- Enrollment
- 136 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2013 – 2014
- U.S. locations
- 1
- States / cities
- Dallas, Texas
- Conditions
- Healthy Men, Male Contraception
- Interventions
- Placebo, 11β-methyl-nortestosterone-dodecylcarbonate
- Drug
- Lead sponsor
- Premier Research
- Other
- Eligibility
- 18 Years to 50 Years · Male only
- Enrollment
- 43 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2017 – 2020
- U.S. locations
- 2
- States / cities
- Torrance, California • Seattle, Washington
- Conditions
- Androgenetic Alopecia
- Interventions
- 5 billion exosomes and saline solution microneedling, 50 billion exosomes and saline solution microneedling
- Combination Product
- Lead sponsor
- Levit Dermatology
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 100 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2024 – 2025
- U.S. locations
- 1
- States / cities
- Brooklyn, New York
- Conditions
- Prostate Cancer
- Interventions
- Coping Skills Training, Prostate Cancer Education
- Behavioral
- Lead sponsor
- Duke University
- Other
- Eligibility
- Male only
- Enrollment
- 62 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2010
- U.S. locations
- 1
- States / cities
- Durham, North Carolina
- Conditions
- Prostate Cancer
- Interventions
- Standard of Care
- Other
- Lead sponsor
- Prostate Cancer Clinical Trials Consortium
- Other
- Eligibility
- 21 Years and older · Male only
- Enrollment
- 5,000 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2032
- U.S. locations
- 48
- States / cities
- Birmingham, Alabama • Tuscaloosa, Alabama • Los Angeles, California + 35 more
- Conditions
- Prostate Cancer
- Interventions
- Sipuleucel-T, APC-Placebo
- Biological
- Lead sponsor
- Dendreon
- Industry
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 512 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2009
- U.S. locations
- 65
- States / cities
- Laguna Hills, California • Loma Linda, California • Los Angeles, California + 49 more
- Conditions
- Prostate Cancer
- Interventions
- Olaparib, Durvalumab
- Drug
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Other
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 5 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2023
- U.S. locations
- 8
- States / cities
- Duarte, California • Chicago, Illinois • Detroit, Michigan + 5 more
- Conditions
- Nocturia
- Interventions
- fedovapagon 1 mg, fedovapagon 2 mg, fedovapagon 4 mg, Placebo ( sugar pill)
- Drug
- Lead sponsor
- Vantia Ltd
- Industry
- Eligibility
- 55 Years and older · Male only
- Enrollment
- 358 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2013
- U.S. locations
- 56
- States / cities
- Birmingham, Alabama • Huntsville, Alabama • Mobile, Alabama + 53 more
- Conditions
- Healthy
- Interventions
- placebo, lixivaptan, moxifloxacin
- Drug
- Lead sponsor
- CardioKine Inc.
- Industry
- Eligibility
- 18 Years to 45 Years
- Enrollment
- 298 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2008
- U.S. locations
- 1
- States / cities
- Austin, Texas
- Conditions
- Neoplasms, Prostate
- Interventions
- dutasteride, placebo, bicalutamide
- Drug
- Lead sponsor
- GlaxoSmithKline
- Industry
- Eligibility
- 40 Years to 90 Years · Male only
- Enrollment
- 127 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2013
- U.S. locations
- 47
- States / cities
- Homewood, Alabama • Huntsville, Alabama • Little Rock, Arkansas + 43 more
- Conditions
- Prostate Cancer
- Interventions
- avodart, Placebo
- Drug
- Lead sponsor
- Bay State Clinical Trials, Inc.
- Other
- Eligibility
- 35 Years to 90 Years · Male only
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2014
- U.S. locations
- 1
- States / cities
- Watertown, Massachusetts
- Conditions
- Prostate Cancer
- Interventions
- Pazopanib, Docetaxel, Prednisone, Pegfilgrastim
- Drug
- Lead sponsor
- Daniel George, MD
- Other
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 36 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2016
- U.S. locations
- 2
- States / cities
- Chicago, Illinois • Durham, North Carolina
- Conditions
- Prostate Cancer
- Interventions
- ARN-509, Abiraterone Acetate, Prednisone
- Drug
- Lead sponsor
- Daniel George, MD
- Other
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 93 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2024
- U.S. locations
- 14
- States / cities
- New Orleans, Louisiana • Baltimore, Maryland • Detroit, Michigan + 11 more